secwatch.observer — SEC 8-K summary
======================================

Issuer:     Niagen Bioscience, Inc. (NAGE)
CIK:        0001386570
Form:       8-K
Filed at:   2022-10-03T23:59:59+00:00
Accession:  0001851734-22-000581
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ChromaDex forms China JV for Tru Niagen, sells $3.1M stock to insiders at $1.25/sh
--------------------------------------------------------------------------------

- Taikuk invests $1M for 11% non-voting stake in JV to commercialize Tru Niagen in China; Blue Hat registration required within 24 months.
- Prior Term Sheet with Crystal Lake and Pioneer Idea terminated; new structure approved by Audit Committee.
- Company sells 2.48M shares at $1.25 for $3.1M to existing holders including CEO Robert Fried; closing expected Oct 7, 2022.
- Shares unregistered, sold under Rule 506; Registration Rights Agreement provides for future resale registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1386570/000185173422000581/0001851734-22-000581-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1386570/000185173422000581/cdxc20220930_8k.htm
  HTML page:      https://secwatch.observer/filing/0001851734-22-000581

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer